Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Quality of life and psychological impact in adult patients with hemorrhagic moyamoya disease who received no surgical revascularization.

Su SH, Hai J, Zhang L, Wu YF, Yu F.

J Neurol Sci. 2013 May 15;328(1-2):32-6. doi: 10.1016/j.jns.2013.02.010. Epub 2013 Mar 15.

PMID:
23498370
2.

Assessment of cognitive function in adult patients with hemorrhagic moyamoya disease who received no surgical revascularization.

Su SH, Hai J, Zhang L, Yu F, Wu YF.

Eur J Neurol. 2013 Jul;20(7):1081-7. doi: 10.1111/ene.12138. Epub 2013 Apr 11.

PMID:
23577654
3.

Outcome in adult patients with hemorrhagic moyamoya disease after combined extracranial-intracranial bypass.

Jiang H, Ni W, Xu B, Lei Y, Tian Y, Xu F, Gu Y, Mao Y.

J Neurosurg. 2014 Nov;121(5):1048-55. doi: 10.3171/2014.7.JNS132434. Epub 2014 Aug 15.

PMID:
25127415
4.

Clinical features, surgical treatment and long-term outcome in adult patients with Moyamoya disease in China.

Bao XY, Duan L, Li DS, Yang WZ, Sun WJ, Zhang ZS, Zong R, Han C.

Cerebrovasc Dis. 2012;34(4):305-13. doi: 10.1159/000343225. Epub 2012 Nov 8.

PMID:
23146868
5.

Symptomatic Moyamoya disease: clinical features and outcome after indirect bypass surgery in four French adults.

Derex L, Doumbé J, Kouamé-Assouan AE, Pelissou-Guyotat I, Morel C, Hermier M, Nighoghossian N, Trouillas P.

J Neurol Sci. 2010 Jan 15;288(1-2):92-5. doi: 10.1016/j.jns.2009.09.031. Epub 2009 Oct 17.

PMID:
19840882
6.

Pediatric stroke among Hong Kong Chinese subjects.

Chung B, Wong V.

Pediatrics. 2004 Aug;114(2):e206-12.

PMID:
15286258
7.

Moyamoya disease presenting with subarachnoid hemorrhage: Clinical features and neuroimaging of a case series.

Wan M, Han C, Xian P, Yang WZ, Li DS, Duan L.

Br J Neurosurg. 2015;29(6):804-10. doi: 10.3109/02688697.2015.1071327. Epub 2015 Aug 24.

PMID:
26313681
8.

Risk Factors for Newly Developed Cerebral Infarction After Surgical Revascularization for Adults with Moyamoya Disease.

Park W, Ahn JS, Lee HS, Park JC, Kwun BD.

World Neurosurg. 2016 Aug;92:65-73. doi: 10.1016/j.wneu.2016.03.053. Epub 2016 Mar 26.

PMID:
27020972
9.

Clinical Features, Surgical Treatment, and Long-Term Outcome in Elderly Patients with Moyamoya Disease.

Ge P, Zhang Q, Ye X, Liu X, Deng X, Wang R, Zhang Y, Zhang D, Zhao J.

World Neurosurg. 2017 Apr;100:459-466. doi: 10.1016/j.wneu.2017.01.055. Epub 2017 Jan 26.

PMID:
28132922
10.

Long-term social outcome in children with moyamoya disease who have reached adulthood.

Phi JH, Wang KC, Cho BK, Lee MS, Lee JH, Yu KS, Hahm BJ, Kim SK.

J Neurosurg Pediatr. 2011 Sep;8(3):303-9. doi: 10.3171/2011.6.PEDS10578.

PMID:
21882923
11.

The current status of the treatment for hemorrhagic type moyamoya disease based on a 1995 nationwide survey in Japan.

Ikezaki K, Fukui M, Inamura T, Kinukawa N, Wakai K, Ono Y.

Clin Neurol Neurosurg. 1997 Oct;99 Suppl 2:S183-6.

PMID:
9409433
12.

Domains and determinants of quality of life after stroke caused by brain infarction.

Kauhanen ML, Korpelainen JT, Hiltunen P, Nieminen P, Sotaniemi KA, Myllylä VV.

Arch Phys Med Rehabil. 2000 Dec;81(12):1541-6.

PMID:
11128887
13.

The natural clinical course of hemodynamically stable adult moyamoya disease.

Cho WS, Chung YS, Kim JE, Jeon JP, Son YJ, Bang JS, Kang HS, Sohn CH, Oh CW.

J Neurosurg. 2015 Jan;122(1):82-9. doi: 10.3171/2014.9.JNS132281.

PMID:
25361479
14.

The impact of stomatological disease on oral health-related quality of life.

Llewellyn CD, Warnakulasuriya S.

Eur J Oral Sci. 2003 Aug;111(4):297-304.

PMID:
12887394
15.

Psychosocial factors, disease status, and quality of life in patients with rheumatoid arthritis.

Kojima M, Kojima T, Ishiguro N, Oguchi T, Oba M, Tsuchiya H, Sugiura F, Furukawa TA, Suzuki S, Tokudome S.

J Psychosom Res. 2009 Nov;67(5):425-31. doi: 10.1016/j.jpsychores.2009.01.001. Epub 2009 Mar 5.

PMID:
19837205
16.

[Relationship between insight and self-reported quality of life among shizophrenic patients].

Aghababian V, Auquier P, Baumstarck-Barrau K, Lançon C.

Encephale. 2011 Jun;37(3):162-71. doi: 10.1016/j.encep.2010.08.011. Epub 2010 Oct 20. French.

PMID:
21703431
17.

Management of adult moyamoya disease.

Wanifuchi H, Takeshita M, Izawa M, Aoki N, Kagawa M.

Neurol Med Chir (Tokyo). 1993 May;33(5):300-5.

18.
19.

Effects of extracranial-intracranial bypass for patients with hemorrhagic moyamoya disease: results of the Japan Adult Moyamoya Trial.

Miyamoto S, Yoshimoto T, Hashimoto N, Okada Y, Tsuji I, Tominaga T, Nakagawara J, Takahashi JC; JAM Trial Investigators.

Stroke. 2014 May;45(5):1415-21. doi: 10.1161/STROKEAHA.113.004386. Epub 2014 Mar 25.

20.

Physical disability, psychological status, and health-related quality of life in older hemodialysis patients and age-matched controls.

Altintepe L, Levendoglu F, Okudan N, Guney I, Savas Cilli A, Ugurlu H, Tonbul Z, Gokbel H, Turk S.

Hemodial Int. 2006 Jul;10(3):260-6.

PMID:
16805887

Supplemental Content

Support Center